Raul Gainetdinov (born September 1, 1964) is a pharmacologist and neuroscientist. The main direction of his research is psychiatric and neurological diseases of the brain, such as

schizophrenia Schizophrenia () is a mental disorder characterized variously by hallucinations (typically, Auditory hallucination#Schizophrenia, hearing voices), delusions, thought disorder, disorganized thinking and behavior, and Reduced affect display, f ...

ADHD Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterised by symptoms of inattention, hyperactivity, impulsivity, and emotional dysregulation that are excessive and pervasive, impairing in multiple ...

, depression and

Parkinson's disease Parkinson's disease (PD), or simply Parkinson's, is a neurodegenerative disease primarily of the central nervous system, affecting both motor system, motor and non-motor systems. Symptoms typically develop gradually and non-motor issues become ...

. He is the author of fundamental scientific works in pharmacology of

dopamine Dopamine (DA, a contraction of 3,4-dihydroxyphenethylamine) is a neuromodulatory molecule that plays several important roles in cells. It is an organic chemical of the catecholamine and phenethylamine families. It is an amine synthesized ...

, β-Arrestins and

NMDA receptors The ''N''-methyl-D-aspartate receptor (also known as the NMDA receptor or NMDAR), is a glutamate receptor and predominantly Ca2+ ion channel found in neurons. The NMDA receptor is one of three types of ionotropic glutamate receptors, the othe ...

. He is a pioneer researcher of

Trace amine-associated receptor Trace amine-associated receptors (TAARs), sometimes referred to as trace amine receptors (TAs or TARs), are a class of G protein-coupled receptors that were discovered in 2001. TAAR1, the first of six functional human TAARs, has gained considerab ...

Education

He earned an MD degree from the Second Moscow Medical Institute (now the

Russian National Research Medical University Pirogov Russian National Research Medical University (formerly known as Russian State Medical University or RSMU) is a medical higher education institution in Moscow, Russia founded in 1906. It is fully accredited and recognized by Russia's Min ...

) in 1988, followed by a PhD degree in Pharmacology in 1992 from the

Russian Academy of Medical Sciences The USSR Academy of Medical Sciences () was the highest scientific and medical organization founded in the Soviet Union founded in 1944. Its successor is the Russian Academy of Medical Sciences founded in 1992, and is a part of the Russian Academy ...

Career

* 1988-1996 PhD student - Senior Scientist, Institute of Pharmacology, Russian Academy of Medical Sciences, Moscow, Russia. * 1996-2008 Postdoctoral Researcher - Associate Research Professor, Department of Cell Biology,

Duke University Duke University is a Private university, private research university in Durham, North Carolina, United States. Founded by Methodists and Quakers in the present-day city of Trinity, North Carolina, Trinity in 1838, the school moved to Durham in 1 ...

, North Carolina, USA. * 2008-2016 Senior Researcher, Department of Neuroscience and Brain Technologies,

Italian Institute of Technology The Istituto Italiano di Tecnologia (IIT) (in English: Italian Institute of Technology) is a scientific research centre based in Genoa (Italy, EU). Its main goal is the advancement of science, in Italy and worldwide, through projects and discove ...

, Genova, Italy. * 2013-2018 Professor,

Skolkovo Institute of Science and Technology The Skolkovo Institute of Science and Technology, or Skoltech, is a private institute located in Moscow, Russia. Skoltech was established in 2011 as part of a multi-year partnership with the Massachusetts Institute of Technology (MIT) Globally ...

* Since 2015 Director of Institute of Translational Biomedicine and Head of Laboratory of Neuroscience and Molecular Pharmacology,

Saint Petersburg State University Saint Petersburg State University (SPBGU; ) is a public research university in Saint Petersburg, Russia, and one of the oldest and most prestigious universities in Russia. Founded in 1724 by a decree of Peter the Great, the university from the be ...

Influence

Since 2018 Raul Gainetdinov has been included in the Web of Science Highly Cited Researchers list. ''h''-index 82. Since 2013 he has been the chairman of the nomenclature committee for

dopamine receptor Dopamine receptors are a class of G protein-coupled receptors that are prominent in the vertebrate central nervous system (CNS). Dopamine receptors activate different effectors through not only G-protein coupling, but also signaling through diff ...

s of

International Union of Basic and Clinical Pharmacology The International Union of Basic and Clinical Pharmacology (IUPHAR) is a voluntary, non-profit association representing the interests of scientists in pharmacology-related fields to facilitate ''Better Medicines through Global Education and Resea ...

(

IUPHAR The International Union of Basic and Clinical Pharmacology (IUPHAR) is a voluntary, non-profit association representing the interests of scientists in pharmacology-related fields to facilitate ''Better Medicines through Global Education and Resea ...

Pictures

References

External links

PubMed search for Raul R. Gainetdinov
{{DEFAULTSORT:Gainetdinov, Raul Living people 1964 births Academic staff of Saint Petersburg State University Russian medical researchers Russian neuroscientists Russian pharmacologists Duke University faculty Academicians of the Russian Academy of Medical Sciences